Squamous Cell Carcinoma in the Diabetic Foot: A Review of Published Case Reports.
- 1Department of Podiatry, School of Allied Health, Auckland University of Technology, Auckland, New Zealand.
- 2Health Sciences University, Bournemouth, UK.
Abstract
Introduction
Squamous cell carcinoma (SCC) is a malignant tumour arising from epidermal keratinocytes and is the second most common form of skin cancer globally. Although relatively rare on the foot, SCC and its variants may occur in people with diabetes and can mimic common diabetes-related foot ulcerations. This diagnostic overlap presents a risk of delayed recognition and treatment. The aim of this review was to synthesise published case reports of SCC occurring in the diabetic foot and to describe patient characteristics, clinical presentation, and outcomes.Methods
A review of case reports was conducted in accordance with the PRISMA guidelines. Electronic databases (Medline, CINAHL, SPORTDiscus and SCOPUS) were searched up to September 2025 using relevant terms for SCC and its variants. Studies describing clinical cases of SCC arising on the foot in individuals with diabetes were included.Results
Thirty-one cases from 13 countries were included. The mean age of patients was 62 years, with a predominance of males (71.0%) and type 2 diabetes (64.5%). Lesions most affected the right foot (64.5%) and were frequently located on the toes or plantar surfaces. The mean lesion duration prior to diagnosis was 61.9 months (range 2-360; n = 25). Initial misdiagnosis was most commonly as a foot ulcer (54.8%), followed by a wart (19.4%) and osteomyelitis (12.9%). Final diagnoses included SCC (51.7%), verrucous carcinoma (35.5%), and Marjolin's ulcer (12.9%). Pain was reported in 58.1% of cases despite neuropathy being present in 45.2%. Recurrence occurred in 16.1% of cases.Conclusions
Squamous cell carcinoma in people with diabetes-related foot disease is rare but frequently misdiagnosed, resulting in prolonged lesion duration prior to diagnosis. Clinicians should maintain a high index of suspicion for malignancy in atypical or non-healing foot lesions, particularly those with unusual features or persistence despite treatment. Early biopsy is essential for timely diagnosis and optimising outcomes.
Related
- Skeletal muscle metastasis from gastric carcinoma: a systematic review of published case reports and case series over six decades.
- Abiotrophia defectiva infective endocarditis: a systematic review of published case reports
- Two cases of large cell neuroendocrine carcinoma of the gallbladder: case reports and systemic literature review
- Synchronous laryngeal squamous cell carcinoma and papillary urothelial carcinoma of the bladder: a case report and literature review
- Prognostic value of the Hippo signaling pathway in oral squamous cell carcinoma: a systematic review and meta-analysis
BibTeX
@article{carroll2026squamous,
title = {{Squamous Cell Carcinoma in the Diabetic Foot: A Review of Published Case Reports.}},
author = {Matthew R Carroll and Ivan R Bristow},
journal = {Journal of foot and ankle research},
year = {2026},
month = oct,
doi = {10.1002/jfa2.70217},
url = {https://europepmc.org/article/MED/42932224},
note = {CC BY},
}
RIS
TY - JOUR
TI - Squamous Cell Carcinoma in the Diabetic Foot: A Review of Published Case Reports.
AU - Matthew R Carroll
AU - Ivan R Bristow
PY - 2026
DA - 2026/10/30
JO - Journal of foot and ankle research
DO - 10.1002/jfa2.70217
UR - https://europepmc.org/article/MED/42932224
AB - Introduction Squamous cell carcinoma (SCC) is a malignant tumour arising from epidermal keratinocytes and is the second most common form of skin cancer globally. Although relatively rare on the foot, SCC and its variants may occur in people with diabetes and can mimic common diabetes-related foot ulcerations. This diagnostic overlap presents a risk of delayed recognition and treatment. The aim of this review was to synthesise published case reports of SCC occurring in the diabetic foot and to describe patient characteristics, clinical presentation, and outcomes.Methods A review of case reports was conducted in accordance with the PRISMA guidelines. Electronic databases (Medline, CINAHL, SPORTDiscus and SCOPUS) were searched up to September 2025 using relevant terms for SCC and its variants. Studies describing clinical cases of SCC arising on the foot in individuals with diabetes were included.Results Thirty-one cases from 13 countries were included. The mean age of patients was 62 years, with a predominance of males (71.0%) and type 2 diabetes (64.5%). Lesions most affected the right foot (64.5%) and were frequently located on the toes or plantar surfaces. The mean lesion duration prior to diagnosis was 61.9 months (range 2-360; n = 25). Initial misdiagnosis was most commonly as a foot ulcer (54.8%), followed by a wart (19.4%) and osteomyelitis (12.9%). Final diagnoses included SCC (51.7%), verrucous carcinoma (35.5%), and Marjolin's ulcer (12.9%). Pain was reported in 58.1% of cases despite neuropathy being present in 45.2%. Recurrence occurred in 16.1% of cases.Conclusions Squamous cell carcinoma in people with diabetes-related foot disease is rare but frequently misdiagnosed, resulting in prolonged lesion duration prior to diagnosis. Clinicians should maintain a high index of suspicion for malignancy in atypical or non-healing foot lesions, particularly those with unusual features or persistence despite treatment. Early biopsy is essential for timely diagnosis and optimising outcomes.
SN - 1757-1146
ER -